| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.524 | 2.226 | 28.769 |
| Total Income - EUR | 0 | 0 | 0 | 19.418 | 0 | 0 | 0 | 4.524 | 2.226 | 38.478 |
| Total Expenses - EUR | 446 | 466 | 0 | 1.108 | 0 | 0 | 152 | 3.127 | 4.781 | 22.163 |
| Gross Profit/Loss - EUR | -446 | -466 | 0 | 18.310 | 0 | 0 | -152 | 1.397 | -2.555 | 16.315 |
| Net Profit/Loss - EUR | -446 | -466 | 0 | 17.728 | 0 | 0 | -152 | 1.397 | -2.555 | 14.658 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Omicron 92 Impex Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.857 | 1.867 | 13.405 |
| Current Assets | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 372 | 1.216 | 16.089 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 64 | 114 | 7.694 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 308 | 1.102 | 8.395 |
| Shareholders Funds | -25.647 | -25.678 | -25.207 | -23.825 | -21.690 | -21.209 | -21.427 | -19.965 | -22.408 | 8.876 |
| Social Capital | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 | 200 |
| Debts | 25.647 | 25.678 | 25.207 | 23.829 | 21.694 | 21.213 | 21.430 | 23.390 | 25.491 | 20.618 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 1 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "7111 - 7111" | |||||||||
| CAEN Financial Year |
7111
|
|||||||||
Comments - Omicron 92 Impex Srl